Guardant Health
In Howard Marks's portfolio · Oaktree Capital Management
Ticker GH.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2025 | Reduce 43% | 22,076,000 | 0.4% |
| Q4 2024 | Add 79% | 38,535,000 | 0.6% |
| Q2 2024 | Buy | 20,116,000 | 0.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.